🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SENEA and executed a BUY strategy, securing a +19.05% net profit.

UPGRADE TO SEE LIVE SIGNALS

$SNDX

Syndax Pharmaceuticals Inc

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP1.14%
MAX GAP RECORD19.56%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.6%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL